Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimary Health Regulatory News (PHP)

Share Price Information for Primary Health (PHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 93.35
Bid: 93.35
Ask: 93.50
Change: 1.70 (1.85%)
Spread: 0.15 (0.161%)
Open: 92.45
High: 93.55
Low: 91.90
Prev. Close: 91.65
PHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - [Primary Healthcare Properties PLC]

27 Feb 2019 13:40



Form 8.3 - [Primary Healthcare Properties PLC]

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Rathbone Brothers Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereePrimary Healthcare Properties PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure26/02/2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:  
InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:15,081,6121.92  
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:15,081,6121.92  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
12.5pPurchase 21,000120.35p
12.5pSale8,999120.30p
12.5pPurchase8,999120.30p

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/AN/A N/AN/AN/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
N/AN/AN/AN/AN/AN/AN/AN/A

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/AN/AN/AN/AN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
N/AN/A N/AN/A

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

 27/02/2019
 Hannah Rimmer – Compliance Department
 0151 236 6666

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.


Date   Source Headline
11th Jan 202211:00 amRNSDirector/PDMR Shareholding
6th Jan 20227:00 amRNSDividend Declaration
17th Dec 20217:00 amRNSAcquisition
16th Dec 20219:00 amRNSDirector Declaration
15th Dec 20217:00 amRNSBoard changes
14th Dec 20213:30 pmRNSDirector/PDMR Shareholding
14th Dec 20213:30 pmRNSDirector/PDMR Shareholding
14th Dec 20217:00 amRNSAcquisition
8th Dec 20214:00 pmRNSDirector/PDMR Shareholding
8th Dec 20214:00 pmRNSDirector/PDMR Shareholding
30th Nov 20215:00 pmRNSDirector/PDMR Shareholding
30th Nov 20215:00 pmRNSDirector/PDMR Shareholding
30th Nov 202112:08 pmRNSDirector/PDMR Shareholding
26th Nov 20215:00 pmRNSTotal Voting Rights
22nd Nov 20211:00 pmRNSApplication for Listing
15th Nov 20217:00 amRNSAcquisition
11th Nov 20217:00 amRNSAcquisition
8th Nov 20214:10 pmRNSDirector/PDMR Shareholding
8th Nov 20214:10 pmRNSDirector/PDMR Shareholding
5th Nov 20215:00 pmRNSConvertible bonds: exchange price adjustment
28th Oct 20217:00 amRNSRefinancing & sustainability linked credit
25th Oct 20212:31 pmRNSHolding(s) in Company
21st Oct 202111:16 amRNSScrip Dividend Reference Price
21st Oct 20219:58 amRNSAcquisition
11th Oct 202110:57 amRNSDirector Declaration
7th Oct 202111:22 amRNSDirector/PDMR Shareholding
7th Oct 202111:00 amRNSDirector/PDMR Shareholding
7th Oct 20217:00 amRNSDividend Declaration
30th Sep 20219:18 amRNSDirector Declaration
23rd Sep 202112:32 pmRNSHolding(s) in Company
17th Sep 20217:00 amRNSLaunch of Community Impact Fund
15th Sep 20213:00 pmRNSDirector/PDMR Shareholding
15th Sep 20213:00 pmRNSDirector/PDMR Shareholding
8th Sep 20214:00 pmRNSDirector/PDMR Shareholding
8th Sep 20214:00 pmRNSDirector/PDMR Shareholding
7th Sep 20217:01 amRNSAdmission of new shares and total voting rights
7th Sep 20217:00 amRNSAcquisition
27th Aug 20217:00 amRNSAcquisition
24th Aug 202111:15 amRNSDirector/PDMR Shareholding
24th Aug 202111:15 amRNSDirector/PDMR Shareholding
20th Aug 20215:00 pmRNSTotal Voting Rights
16th Aug 20214:55 pmRNSApplication for listing
6th Aug 20219:00 amRNSDirector/PDMR Shareholding
6th Aug 20219:00 amRNSDirector/PDMR Shareholding
30th Jul 20211:00 pmRNSConvertible Bond: exchange price adjustment
28th Jul 20217:00 amRNSInterim Results
20th Jul 20217:00 amRNSInvestor Presentation
15th Jul 20214:27 pmRNSScrip dividend reference price
12th Jul 20219:28 amRNSHolding(s) in Company
7th Jul 20214:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.